How do pediatric patients perceive adverse drug events of anticonvulsant drugs? A survey

被引:6
作者
Neininger, Martina Patrizia [1 ,2 ]
Woltermann, Sarah [1 ,2 ,3 ]
Jeschke, Sarah [4 ]
Herziger, Birthe [4 ]
Mueller, Ruth Melinda [4 ]
Kiess, Wieland [3 ]
Bertsche, Thilo [1 ,2 ]
Bertsche, Astrid [3 ,4 ]
机构
[1] Univ Leipzig, Med Fac, Inst Pharm, Drug Safety Ctr, Bruderstr 32, D-04103 Leipzig, Germany
[2] Univ Leipzig, Med Fac, Inst Pharm, Clin Pharm, Bruderstr 32, D-04103 Leipzig, Germany
[3] Univ Hosp Children & Adolescents, Ctr Pediat Res, Liebigstr 20a, D-04103 Leipzig, Germany
[4] Univ Hosp Children & Adolescents, Neuropaediat, Ernst Heydemann Str 8, D-18057 Rostock, Germany
关键词
Adverse drug events (ADEs); Anticonvulsants; Children; Adolescents; Perceptions; Interview; SUDDEN UNEXPECTED DEATH; QUALITY-OF-LIFE; ANTIEPILEPTIC DRUGS; WEIGHT-GAIN; EPILEPSY; CHILDREN; ADOLESCENTS; OXCARBAZEPINE; VALPROATE; FEAR;
D O I
10.1007/s00431-020-03571-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Anticonvulsant drugs have a high risk of adverse drug events. Little is known about the perception of those events by pediatric patients. We performed a survey in the neuropediatric departments of two university hospitals. Using a questionnaire, we interviewed patients aged 6-18 years with current anticonvulsant treatment regarding (i) their fears about potential adverse drug events, (ii) experienced adverse drug events, and (iii) perceived burden of experienced adverse drug events. One hundred patients took part in the interview. (i) 40 (40%) expressed fears that the medication could harm them. Eighteen of 40 (45%) named fears concerning specific adverse drug events. Of those, 12/18 (67%) feared neurologic or psychiatric symptoms. (ii) 37 (37%) of children described altogether 60 experienced adverse drug events. Of those, 38 (63%) concerned neurologic or psychiatric symptoms. (iii) 32/37 (82%) children who experienced adverse drug events felt bothered by the experienced event. Among others, they described an emotional burden (11/37, 30%), and restrictions in school performance (8/37, 22%) and favorite leisure activities (4/37, 11%). Conclusion: School-aged children are well able to describe adverse drug events of their anticonvulsant medication. Almost two thirds of the described events concern neurologic or psychiatric symptoms that cause an emotional burden and restrictions according to the patients. What is Known: center dot Anticonvulsants have a high potential of adverse drug events. center dot In an earlier survey, parents expressed fears of severe adverse drug events such as liver failure, which seldom occur, and reported a high number of neurological and psychological adverse drug events. What is New: center dot Many children fear that their anticonvulsants could harm them, and they fear and experience neurological and psychological adverse drug events. center dot According to the children, adverse drug events cause an emotional burden and restrictions in school performance and favorite leisure activities.
引用
收藏
页码:1413 / 1420
页数:8
相关论文
共 50 条
  • [41] Maxillo-Mandibular Reconstruction in Pediatric Patients: How To Do It?
    Valentini, Valentino
    Califano, Luigi
    Cassoni, Andrea
    Marco, Della Monaca
    Raponi, Ingrid
    Priore, Paolo
    Fadda, Maria Teresa
    Orabona, Giovanni Dell'Aversana
    Terenzi, Valentina
    JOURNAL OF CRANIOFACIAL SURGERY, 2018, 29 (03) : 761 - 766
  • [42] Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures
    Butler, Anne M.
    Brown, Derek S.
    Durkin, Michael J.
    Sahrmann, John M.
    Nickel, Katelin B.
    O'Neil, Caroline A.
    Olsen, Margaret A.
    Hyun, David Y.
    Zetts, Rachel M.
    Newland, Jason G.
    JAMA NETWORK OPEN, 2022, 5 (05) : E2214153
  • [43] Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review
    Druyts, Eric
    Zoratti, Michael J.
    Toor, Kabirraaj
    Wu, Ping
    Kanji, Salmaan
    Rabheru, Kiran
    Mills, Edward J.
    Thorlund, Kristian
    BMC PEDIATRICS, 2016, 16
  • [44] Healthcare professionals and pharmacovigilance of pediatric adverse drug reactions: a 5-year analysis of Adverse Events Reporting System Database of the Food and Drug Administration
    Bigi, Caterina
    Tuccori, Marco
    Bocci, Guido
    MINERVA PEDIATRICS, 2022, 74 (03): : 272 - 280
  • [45] Off-Label and Unlicensed Medication Use and Associated Adverse Drug Events in a Pediatric Emergency Department
    Phan, Hanna
    Leder, Marc
    Fishley, Matthew
    Moeller, Matthew
    Nahata, Milap
    PEDIATRIC EMERGENCY CARE, 2010, 26 (06) : 424 - 430
  • [46] Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project
    de Bie, Sandra
    Ferrajolo, Carmen
    Straus, Sabine M. J. M.
    Verhamme, Katia M. C.
    Bonhoeffer, Jan
    Wong, Ian C. K.
    Sturkenboom, Miriam C. J. M.
    PLOS ONE, 2015, 10 (06):
  • [47] Do patients trust the FDA?: a survey assessing how patients view the generic drug approval process
    Kesselheim, Aaron S.
    Gagne, Joshua J.
    Franklin, Jessica M.
    Eddings, Wesley
    Fulchino, Lisa A.
    Campbell, Eric G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (06) : 694 - 701
  • [48] Adverse Events of Factor Xa Inhibitors in Pediatric Patients: A Meta-analysis and Pharmacovigilance Study
    Chong, Shan
    Sun, Lan
    Mu, Guangyan
    Hua, Manqi
    Xiang, Qian
    Cui, Yimin
    PEDIATRIC DRUGS, 2025, : 351 - 366
  • [49] How do Lebanese patients perceive the ideal doctor based on the CanMEDS competency framework?
    Aoun, Mabel
    Sleilaty, Ghassan
    Abou Jaoude, Simon
    Chelala, Dania
    Moussa, Ronald
    BMC MEDICAL EDUCATION, 2019, 19 (01)
  • [50] Clobazam and Aggression-Related Adverse Events in Pediatric Patients With Lennox-Gastaut Syndrome
    Paolicchi, Juliann M.
    Ross, Gail
    Lee, Deborah
    Drummond, Rebecca
    Isojarvi, Jouko
    PEDIATRIC NEUROLOGY, 2015, 53 (04) : 338 - 342